Journal Papers, Abstracts, and Commentaries
|
Once vs. twice-daily lopinavir/ritonavir in
HIV-1-infected children.
Paediatric European Network for Treatment of AIDS (PENTA).
AIDS. 2015 Nov
28;29(18):2447-57
Abstract
Lopinavir Dosing in HIV-Infected Children in
the United Kingdom and Ireland.
Donegan K, Doerholt K, Judd A,
et
al
Pediatr Infect Dis J.
2012 Oct 16
Abstract
Once- versus twice-daily lopinavir/ritonavir tablets in
virologically suppressed, HIV-infected, treatment-experienced children:
comparative pharmacokinetics and virological outcome after switching to
once-daily lopinavir/ritonavir.
Chokephaibulkit K, Nuntarukchaikul
M, Phongsamart W,
et al
Antimicrob Chemother. 2012 Aug 23.
Abstract
Lopinavir/ritonavir exposure in treatment-naive
HIV-infected children following twice
or once daily administration.
Rosso R, Di Biagio A, Dentone C, et al
J Antimicrob Chemother.
2006 Apr 10;
Abstract |
Journal Papers, Abstracts, and Commentaries
|
|
Impact
of Single Nucleotide Polymorphisms on Plasma Concentrations of Efavirenz
and Lopinavir/ritonavir in Chinese Children Infected with the Human
Immunodeficiency Virus.
Liu X, Ma Q, Zhao Y,
Pharmacotherapy. 2017 Jul 17
Abstract
Switching to efavirenz versus remaining on ritonavir-boosted lopinavir
in HIV-infected children exposed to nevirapine: long-term outcomes of a
randomized trial.
Murnane PM, Strehlau R, Shiau S,
et al
Clin Infect Dis. 2017 Apr
17
Abstract
Long-Term Lopinavir/Ritonavir Monotherapy in HIV-Infected
Children.
Kosalaraksa P, Ananworanich J, Puthanakit T,
et al
Pediatr Infect Dis J.
2012 Nov 27
Abstract
Monoboosted lopinavir/ritonavir as simplified
second-line maintenance therapy in
virologically suppressed children.
Bunupuradah T, Kosalaraksa P, Puthanakit T, et al
AIDS.
2010 Dec 13.
Abstract |
|
Journal Papers, Abstracts, and Commentaries
|
|
Insulin resistance and lipid Profiles in HIV-infected Thai
children receiving lopinavir/ritonavir-based highly active antiretroviral
therapy.
Dejkhamron P,
Unachak K, Aurpibul L, Sirisanthana V.
J Pediatr Endocrinol Metab.
2013 Nov 21:1-10.
Abstract
Metabolic abnormalities and body composition of HIV-infected
children on Lopinavir or Nevirapine-based antiretroviral therapy.
Arpadi S, Shiau S, Strehlau R,
et al
Arch Dis Child. 2012
Dec 5
Abstract
Association between Lipodystrophy and Leptin in HIV
-1-Infected Children Receiving
Lopinavir/Ritonavir-Based Therapy
Resino S, Palladino C, Lorente R, et al
Pediatr Infect Dis J.
2010 Apr 2.
Abstract |
Lopinavir/Ritonavir
Pediatric Indications: Main Page |
|